Dimensional Fund Advisors LP Exelixis, Inc. Transaction History

Dimensional Fund Advisors LP

$418 Billion
Q2 2025

A detailed history of Dimensional Fund Advisors LP transactions in Exelixis, Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 3,761,316 shares of EXEL stock, worth $141 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

3,761,316

Previous 4,235,375 11.19%

Holding current value

$141 Million

Previous $156 Million 6.03%

% of portfolio

0.04%

Previous 0.04%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 12, 2025	SELL	$34.13 - $46.26 $16.2 Million - $21.9 Million	-474,059 Reduced 11.19%	3,761,316 $166 Million
Q1 2025 May 13, 2025	SELL	$32.38 - $39.16 $28 Million - $33.8 Million	-864,031 Reduced 16.94%	4,235,375 $156 Million
Q4 2024 Feb 13, 2025	SELL	$25.39 - $36.46 $3.9 Million - $5.6 Million	-153,568 Reduced 2.92%	5,099,406 $170 Million
Q3 2024 Nov 07, 2024	BUY	$21.96 - $27.6 $2.54 Million - $3.2 Million	115,773 Added 2.25%	5,252,974 $136 Million
Q2 2024 Aug 09, 2024	BUY	$20.34 - $23.73 $7.12 Million - $8.3 Million	349,837 Added 7.31%	5,137,201 $115 Million
Q1 2024 May 10, 2024	BUY	$20.17 - $23.93 $4.58 Million - $5.43 Million	226,847 Added 4.97%	4,787,364 $114 Million
Q4 2023 Feb 07, 2024	SELL	$19.25 - $24.13 $633,787 - $794,456	-32,924 Reduced 0.72%	4,560,517 $109 Million
Q3 2023 Nov 09, 2023	SELL	$19.04 - $22.74 $2.33 Million - $2.78 Million	-122,251 Reduced 2.59%	4,593,441 $100 Million
Q2 2023 Aug 09, 2023	BUY	$18.17 - $20.48 $1.14 Million - $1.29 Million	62,860 Added 1.35%	4,715,692 $90.1 Million
Q1 2023 May 12, 2023	BUY	$16.3 - $19.41 $4.57 Million - $5.44 Million	280,504 Added 6.42%	4,652,832 $90.3 Million
Q4 2022 Feb 09, 2023	BUY	$14.96 - $17.39 $5.04 Million - $5.86 Million	336,879 Added 8.35%	4,372,328 $70.1 Million
Q3 2022 Nov 10, 2022	BUY	$15.68 - $22.27 $4.01 Million - $5.7 Million	255,886 Added 6.77%	4,035,449 $63.3 Million
Q2 2022 Aug 12, 2022	BUY	$17.44 - $23.16 $848,176 - $1.13 Million	48,634 Added 1.3%	3,779,563 $78.7 Million
Q1 2022 May 13, 2022	BUY	$17.03 - $22.67 $5.91 Million - $7.87 Million	346,981 Added 10.25%	3,730,929 $84.6 Million
Q4 2021 Feb 09, 2022	BUY	$15.84 - $21.88 $9.25 Million - $12.8 Million	584,112 Added 20.86%	3,383,948 $61.9 Million
Q3 2021 Nov 12, 2021	BUY	$16.3 - $21.14 $10.9 Million - $14.2 Million	671,706 Added 31.56%	2,799,836 $59.2 Million
Q2 2021 Aug 12, 2021	BUY	$17.95 - $25.56 $5,977 - $8,511	333 Added 0.02%	2,128,130 $38.8 Million
Q1 2021 May 14, 2021	SELL	$20.53 - $25.22 $588,903 - $723,435	-28,685 Reduced 1.33%	2,127,797 $48.1 Million
Q4 2020 Feb 25, 2021	BUY	$18.39 - $24.8 $39.7 Million - $53.5 Million	2,156,482 New	2,156,482 $43.3 Million

Others Institutions Holding EXEL

# of Institutions

685

Shares Held

260M

Call Options Held

1.41M

Put Options Held

1.55M

View Full List

About EXELIXIS, INC.

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $12.1B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

More about EXEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.

Account

Dimensional Fund Advisors LP Exelixis, Inc. Transaction History